These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6974264

  • 1. The secondary cytotoxic response to allogeneic cells: the specificity of secondary cytotoxic effectors differs from that of primary effectors.
    Taniguchi K, Nomoto K, Kubo C, Nanishi F.
    Jpn J Exp Med; 1981 Apr; 51(2):89-95. PubMed ID: 6974264
    [Abstract] [Full Text] [Related]

  • 2. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N, Fontaine P, Perreault C.
    Transplantation; 1994 Jul 15; 58(1):59-67. PubMed ID: 8036709
    [Abstract] [Full Text] [Related]

  • 3. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM, Zarling JM.
    J Immunol; 1983 Aug 15; 131(2):1017-23. PubMed ID: 6223084
    [Abstract] [Full Text] [Related]

  • 4. Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells.
    Truitt GA, Rich RR, Rich SS.
    J Immunol; 1977 Jul 15; 119(1):31-7. PubMed ID: 874322
    [Abstract] [Full Text] [Related]

  • 5. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.
    Fink PJ, Rammensee HG, Bevan MJ.
    J Immunol; 1984 Oct 15; 133(4):1775-81. PubMed ID: 6332132
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ, Levy RB, Shearer GM.
    J Immunol; 1981 Apr 15; 126(4):1255-9. PubMed ID: 6970767
    [Abstract] [Full Text] [Related]

  • 7. Effect of carrageenan on the induction of cell-mediated cytotoxic responses in vivo.
    Sakemi T, Kuroiwa A, Nomoto K.
    Immunology; 1980 Oct 15; 41(2):297-302. PubMed ID: 6969217
    [Abstract] [Full Text] [Related]

  • 8. Dissociated and reconstituted subcellular alloantigen capable of stimulating mouse cytotoxic T lymphocytes in vitro.
    Fast LD, Fan DP.
    J Immunol; 1978 Apr 15; 120(4):1092-6. PubMed ID: 76659
    [Abstract] [Full Text] [Related]

  • 9. Young F mice spontaneously generate cytotoxic T cells against parental targets.
    Ishikawa H, Dutton RW.
    J Immunol; 1979 Nov 15; 123(5):2034-9. PubMed ID: 314956
    [Abstract] [Full Text] [Related]

  • 10. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
    Gooding LR, Edwards CB.
    J Immunol; 1980 Mar 15; 124(3):1258-62. PubMed ID: 6244348
    [Abstract] [Full Text] [Related]

  • 11. The induction of alloreactive cytotoxic responses in vivo are inhibited by pretreatment with M is-disparate cells.
    Hayes RL, Claman HN.
    J Immunol; 1982 Jul 15; 129(1):232-5. PubMed ID: 6806359
    [Abstract] [Full Text] [Related]

  • 12. Limitations of recognition of modified-self by alloantigen-activated cytotoxic T lymphocytes.
    Ballas ZK.
    J Immunol; 1981 Oct 15; 127(4):1589-91. PubMed ID: 6168697
    [Abstract] [Full Text] [Related]

  • 13. The effects of neuraminidase and galactose oxidase on murine lymphocytes. I. Evidence for the differential delivery of signal(s) leading to cell proliferation and the differentiation of cytotoxic T cells.
    Kuppers RC, Henney CS.
    J Immunol; 1977 Dec 15; 119(6):2163-71. PubMed ID: 303259
    [Abstract] [Full Text] [Related]

  • 14. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
    Sabapathy TK, Cheng Q, Hui KM.
    Cell Immunol; 1995 Nov 15; 166(1):141-53. PubMed ID: 7585974
    [Abstract] [Full Text] [Related]

  • 15. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
    Ishikawa T, Kakumu S, Yoshioka K, Yamada M, Tanaka K, Higashi Y, Takayanagi M, Okumura A, Kojima A, Tamura T.
    Immunology; 1993 Oct 15; 80(2):313-8. PubMed ID: 8262560
    [Abstract] [Full Text] [Related]

  • 16. Studies on T cell clonal expansion. I. Suppression of killer T cell production in vivo.
    Kamat R, Henney CS.
    J Immunol; 1975 Dec 15; 115(6):1592-8. PubMed ID: 810513
    [Abstract] [Full Text] [Related]

  • 17. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes.
    Tyler JD, Steinmuller D.
    J Immunol; 1981 May 15; 126(5):1759-63. PubMed ID: 7012238
    [Abstract] [Full Text] [Related]

  • 18. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR.
    J Immunol; 1982 Mar 15; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract] [Full Text] [Related]

  • 19. In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens.
    Rosenberg SA, Schwarz S, Spiess PJ.
    J Immunol; 1978 Nov 15; 121(5):1951-5. PubMed ID: 309485
    [Abstract] [Full Text] [Related]

  • 20. Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity.
    Vánky FT, Vose BM, Fopp M, Klein E.
    J Natl Cancer Inst; 1979 Jun 15; 62(6):1407-13. PubMed ID: 86634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.